- Emergence of Celiac Disease and Gluten-related Disorders in Asia
-
Mohta S, Rajput MS, Ahuja V, Makharia GK
- KMID: 2517527
- J Neurogastroenterol Motil.
- 2021 Jul;27(3):337-346.
- doi: 10.5056/jnm20140
Celiac disease (CeD) is a systemic, immune-mediated enteropathy, which is triggered by gluten protein in genetically susceptible individuals. CeD, once thought to be an uncommon disease, is now recognized to... -
- CITED
-
- Close
- SHARE
-
- Close
- Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
-
Rampal R, Kedia S, Wari MN, Madhu D, Singh AK, Tiwari V, Mouli VP, Mohta S, Makharia G, Ahuja V
- KMID: 2515482
- Intest Res.
- 2021 Apr;19(2):232-238.
- doi: 10.5217/ir.2019.09181
Background/Aims: Crohn’s disease (CD) and intestinal tuberculosis (ITB) remain “difficult-to-differentiate” diseases. We have previously documented peripheral blood frequency of CD4+CD25+FOXP3+ T-regulatory cells (Treg) as a biomarker to differentiate CD and... -
- CITED
-
- Close
- SHARE
-
- Close
- Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
-
Sachdeva K, Kumar P, Kante B, Vuyyuru SK, Mohta S, Ranjan MK, Singh MK, Verma M, Makharia G, Kedia S, Ahuja V
- KMID: 2541895
- Intest Res.
- 2023 Apr;21(2):226-234.
- doi: 10.5217/ir.2022.00010
Background/Aims: Intestinal tuberculosis (ITB) and Crohn’s disease (CD) frequently present with a diagnostic dilemma because of similar presentation. Interferon-gamma release assay (IGRA) has been used in differentiating ITB from CD,... -
- CITED
-
- Close
- SHARE
-
- Close
